AlphAIalphai — Financial news for AI agents
yahoo.comAUG 33 min read$AHCO

AdaptHealth (AHCO) Reports Earnings Tomorrow: What To Expect

AdaptHealth Corp. (NASDAQ:AHCO) will report earnings Tuesday before market open. The prior quarter showed revenue of $819.8 million, up 5.4% year over year, beating revenue estimates but missing EPS expectations. For the upcoming quarter, analysts expect revenue growth of 5.9% and have largely held estimates steady. The average analyst price target is $14.14 vs $10.80.

Original reporting
yahoo.com
Published Aug 3, 2026, 6:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 6:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
AdaptHealth (AHCO) Reports Earnings Tomorrow: What To Expect — source image
Source · yahoo.com
Decision brief

The 30-second read

$AHCONeutralMed
01

Why it matters

Traders may use the preview to calibrate expectations for revenue growth versus EPS execution, but the article itself does not add new fundamental disclosures.

02

Market read

This is an earnings preview with consensus and peer read-through, useful for positioning ahead of the print but not a new disclosure.

03

What to watch

The article highlights revenue expectations but does not discuss margin, cash flow, or guidance details that typically drive the largest earnings reactions.

Relevance 5/10Novelty 4/10Timing: pre-market earnings scheduled for Tuesday

Background

The piece frames AdaptHealth’s upcoming earnings as a test of whether revenue growth can offset prior EPS misses.

Company-level read

Ticker impact

$AHCONeutralMedium confidence
Context

AdaptHealth (AHCO) is scheduled to report earnings Tuesday pre-market, with the article citing revenue growth expectations and prior EPS misses.

Expected impact

Likely volatility around the pre-market print, with focus on whether EPS miss risk persists versus revenue growth.

Evidence & confidence

The text is a preview: it references last quarter’s beat/miss mix and current consensus growth, but does not disclose any fresh company-specific update that would reprice the stock immediately.

Market effects

Sector

Could influence sentiment for senior health, home health, and hospice peers if results confirm or break the segment’s revenue trajectory.

Regional

No specific regional impact described.

Global

Primarily US healthcare services read-through; no global catalyst mentioned.

Counterpoint

What could challenge this read

If the market is already positioned for modest revenue growth, any EPS normalization could drive upside even without a revenue beat.

Key entities

  • company
    AdaptHealth Corp.

    NASDAQ-listed healthcare services provider reporting earnings Tuesday before market hours.

  • company
    BrightSpring Health Services

    Peer cited as having delivered strong year-on-year revenue growth in Q2.

  • company
    Chemed

    Peer cited as topping revenue estimates and trading up after results.

Read at source← All news

Related articles

AUG 6
$AHCOHighAI 9/10

AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance

AdaptHealth Corp. (NASDAQ:AHCO) shares fell about 13% premarket after Q2 2026 results missed expectations and the company cut full-year guidance. It reported a net loss of $0.99 per share and revenue of $740.3M versus $848.9M expected. FY revenue guidance was lowered to $2.85B-$2.89B from about $3.49B, with adjusted EBITDA $490M-$520M and free cash flow $80M-$120M.

yahoo.com4 min
AUG 4
$AHCOHighAI 9/10

Why AdaptHealth (AHCO) Stock Is Trading Lower Today

AdaptHealth Corp. (AHCO) shares fell about 39.5% after its Q2 results missed expectations and it cut full-year guidance. The company reported a GAAP loss of $0.99 per share versus a $0.15 gain estimate, and revenue of $740.3 million versus $847.2 million expected. It lowered 2026 revenue guidance midpoint to $2.87B from $3.49B and adjusted EBITDA to $490M-$520M, citing West Coast partnership issues and a manufacturer price increase.

financialcontent.com6 min
AUG 4
$AHCOMedAI 8/10

Why is AdaptHealth stock plummeting today?

AdaptHealth (AHCO) shares fell about 22% in pre-open after it reported Q2 2026 results. Analysts expected EPS of $0.15–$0.18 on revenue near $849M. The company has posted GAAP losses of $0.12 in Q1 2026 and $0.76 in Q4 2025. It also agreed to sell its Diabetes Health segment to Cardinal Health for $235M, with guidance to be addressed on the earnings call.

investing.com2 min
AUG 4
$AHCOHigh

AdaptHealth Corp. (AHCO): Results of Operations and Financial Condition

AdaptHealth Corp. (AHCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ahco-20260804x8k_ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2026 RESULTS CONSHOHOCKEN, Pa. – August 4, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing

SEC EDGAR 8-K7 min
JUL 20
$CAHMedAI 9/10

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million By Reuters

Cardinal Health (CAH) agreed to buy AdaptHealth’s diabetes health business for $235 million cash and to acquire Strive Medical in a separate deal, for about $360 million total, to expand its at-Home Solutions and diabetes care. Cardinal said the deals should add to adjusted EPS within 12 months after closing. AdaptHealth and Strive Medical described their diabetes and urology-focused services.

investing.com4 min